$SUNPHARMA Sun Pharmaceutical continues to strengthen its leadership with a diversified portfolio spanning specialty medicines, branded formulations, generics, and active pharmaceutical ingredients. Growth in specialty products, expanding global presence, and sustained demand in the domestic formulations business support long-term revenue visibility. Continued investments in research, product innovation, and complex generics enhance its competitive positioning across key therapeutic segments. However, regulatory inspections, pricing pressure in global generic markets, currency fluctuations, litigation risks, and raw material cost movements remain important factors influencing earnings growth and overall financial performance. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link visit website www dot investmentcure dot com *****

#EquityResearch

970 likes·32 comments